Pfizer CEO Albert Bourla on Tuesday said uncertainty around President Donald Trump’s planned pharmaceutical tariffs is deterring the company from further investing in U.S. manufacturing and research and development. Bourla’s remarks on the company’s first-quarter earnings call came in response to a question about what Pfizer wants to see from tariff negotiations that would push…
Tech is saving Hollywood — though not in the way you might think. Back in 2022, e-commerce giant and…
Nvidia blasted Anthropic Thursday in a rare public clash over artificial intelligence policy with U.S. chip export restrictions set to take effect. “American firms should focus…
Nvidia CEO Jensen Huang said on Wednesday that China is “not behind” in artificial intelligence, and that Huawei is “one…
Pfizer CEO Albert Bourla on Tuesday said uncertainty around President Donald Trump’s planned pharmaceutical tariffs is deterring the company from further investing…
President Donald Trump used to refer to Jeff Bezos as “Jeff Bozo.” Now, after more drama between the two men, Trump is calling the…
International Business Machines Corporation on Monday announced it will invest $150 billion in the U.S. over the next five years,…
JetBlue Airways is getting ready to announce a partnership with another U.S. airline with a larger network in the coming…
Pfizer CEO Albert Bourla on Tuesday said uncertainty around President Donald Trump’s planned pharmaceutical tariffs is deterring the company from further investing…